Literature DB >> 21258838

Nephrotic syndrome developing during induction chemotherapy for childhood acute lymphoblastic leukemia.

Chanel Prestidge1, Shahrad Rod Rassekh2, Douglas G Matsell3.   

Abstract

This report is the first to document minimal change nephrotic syndrome occurring during induction chemotherapy for childhood acute lymphoblastic leukemia (ALL). This occurrence lends further support to the theory of immune cell dysregulation being central to the pathogenesis of nephrotic syndrome in ALL, rather than alternative postulations that this association is due to an increased risk of malignancy secondary to prior immunosuppressive treatment for nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258838     DOI: 10.1007/s10157-010-0401-1

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  25 in total

1.  Paraneoplastic glomerulopathies: new insights into an old entity.

Authors:  P M Ronco
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

2.  T-cell lineage acute lymphoblastic leukemia with chromosome 5 abnormality in a patient with Crohn's disease and lipoid nephrosis.

Authors:  L Pérard; X Thomas; H Jaumain; G Theuil; M Bret; B Coronel; C Charrin; P Boulétreau
Journal:  Ann Hematol       Date:  2000-04       Impact factor: 3.673

3.  A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening.

Authors:  Djillali Sahali; André Pawlak; Asta Valanciuté; Philippe Grimbert; Philippe Lang; Philippe Remy; Albert Bensman; Georges Guellën
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

Review 4.  Circulating mediators of proteinuria in idiopathic minimal lesion nephrotic syndrome.

Authors:  E H Garin
Journal:  Pediatr Nephrol       Date:  2000-08       Impact factor: 3.714

5.  Proteomic analysis of mononuclear cells of patients with minimal-change nephrotic syndrome of childhood.

Authors:  Elsa González; Thomas Neuhaus; Markus J Kemper; Eric Girardin
Journal:  Nephrol Dial Transplant       Date:  2008-08-12       Impact factor: 5.992

6.  Pathogenesis of lipoid nephrosis: a disorder of T-cell function.

Authors:  R J Shalhoub
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

7.  Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.

Authors:  Ali R Jazirehi; Sara Huerta-Yepez; Genhong Cheng; Benjamin Bonavida
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

Review 8.  Acute lymphoblastic leukemia in a child with nephrotic syndrome.

Authors:  Monica Bhatia; Kanwal Kher; Caterina P Minniti
Journal:  Pediatr Nephrol       Date:  2004-09-14       Impact factor: 3.714

9.  Acute lymphoblastic leukaemia after treatment of nephrotic syndrome with immunosuppressive drugs.

Authors:  W Kuis; J de Kraker; R H Kuijten; R A Donckerwolcke; P A Voûte
Journal:  Helv Paediatr Acta       Date:  1976-06

10.  CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes.

Authors:  L E Hultin; M A Hausner; P M Hultin; J V Giorgi
Journal:  Cytometry       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.